Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The quorum sensing regulatory system is a sophisticated bacterial communication mechanism that allows populations to coordinate gene expression based on cell density (Miller & Bassler, 2001, Annual Review of Microbiology). Bacteria produce, release, and detect chemical signaling molecules called autoinducers; when the concentration of these molecules reaches a threshold, the population collectively alters its behavior (Rutherford & Bassler, 2012, Cold Spring Harbor Perspectives in Medicine). This system is a critical regulator of virulence factors, biofilm formation, and antibiotic resistance in many pathogenic bacteria, such as Pseudomonas aeruginosa and Staphylococcus aureus (Defoirdt, 2018, Trends in Microbiology). As a therapeutic target, the quorum sensing system offers an anti-virulence approach, aiming to disarm pathogens rather than killing them directly, which may reduce the selective pressure for antibiotic resistance (Hentzer et al., 2003, EMBO Journal). Drugs targeting this system, known as quorum sensing inhibitors or quorum-quenching agents, work by inhibiting signal synthesis, degrading signaling molecules, or blocking receptor binding (LaSarre & Federle, 2013, Microbiology and Molecular Biology Reviews). While promising for treating chronic and multidrug-resistant infections, challenges include ensuring specificity to pathogens to avoid disrupting the host microbiome and achieving sufficient penetration into complex biofilms (Whiteley et al., 2017, Nature).
Inhibition of autoinducer synthesis (synthase inhibitors), enzymatic degradation of signaling molecules (quorum quenching), and competitive antagonism of quorum sensing receptors (LuxR-type or histidine kinases) to prevent the activation of virulence-related genes.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Quorum sensing regulatory system (QS) (QS).